Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Enhancement of human melanoma antigen expression by IFN-beta.

Dunn IS, Haggerty TJ, Kono M, Durda PJ, Butera D, Macdonald DB, Benson EM, Rose LB, Kurnick JT.

J Immunol. 2007 Aug 15;179(4):2134-42.

2.

Role of the mitogen-activated protein kinase signaling pathway in the regulation of human melanocytic antigen expression.

Kono M, Dunn IS, Durda PJ, Butera D, Rose LB, Haggerty TJ, Benson EM, Kurnick JT.

Mol Cancer Res. 2006 Oct;4(10):779-92.

3.

Induction of "antigen silencing" in melanomas by oncostatin M: down-modulation of melanocyte antigen expression.

Durda PJ, Dunn IS, Rose LB, Butera D, Benson EM, Pandolfi F, Kurnick JT.

Mol Cancer Res. 2003 Apr;1(6):411-9.

4.

A novel autocrine pathway of tumor escape from immune recognition: melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down-modulation of its promoter.

Kurnick JT, Ramirez-Montagut T, Boyle LA, Andrews DM, Pandolfi F, Durda PJ, Butera D, Dunn IS, Benson EM, Gobin SJ, van den Elsen PJ.

J Immunol. 2001 Aug 1;167(3):1204-11.

5.

The binding of a glycoprotein 120 V3 loop peptide to HIV-1 neutralizing antibodies. Structural implications.

Wu G, MacKenzie R, Durda PJ, Tsang P.

J Biol Chem. 2000 Nov 24;275(47):36645-52.

6.

NMR study and comparison of the antigenic properties of a peptide recognized by two HIV-1 neutralizing antibodies.

Tsang P, Mu X, Wu G, Durda PJ.

J Mol Recognit. 1997 Nov-Dec;10(6):256-61.

PMID:
9770649
7.

Kinetics of soluble interleukin-2 receptor after mechanical and burn trauma.

Schinkel C, Zimmer S, Durda PJ, Höcherl E, Herndon DN, Faist E.

J Burn Care Rehabil. 1997 May-Jun;18(3):210-3.

PMID:
9169943
8.
9.

An enzyme-linked immunosorbent assay for the measurement of human IgA antibody responses to Epstein-Barr virus membrane antigen.

Durda PJ, Sullivan M, Kieff E, Pearson GR, Rabin H.

Intervirology. 1993;36(1):11-9.

PMID:
8225907
10.

Neutralizing activity of anti-peptide antibodies against the principal neutralization domain of human immunodeficiency virus type 1.

Langedijk JP, Back NK, Durda PJ, Goudsmit J, Meloen RH.

J Gen Virol. 1991 Oct;72 ( Pt 10):2519-26.

PMID:
1919529
11.

In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein.

Pincus SH, Cole RL, Hersh EM, Lake D, Masuho Y, Durda PJ, McClure J.

J Immunol. 1991 Jun 15;146(12):4315-24.

PMID:
1710247
12.

HIV-1 neutralizing monoclonal antibodies induced by a synthetic peptide.

Durda PJ, Bacheler L, Clapham P, Jenoski AM, Leece B, Matthews TJ, McKnight A, Pomerantz R, Rayner M, Weinhold KJ.

AIDS Res Hum Retroviruses. 1990 Sep;6(9):1115-23. Erratum in: AIDS Res Hum Retroviruses 1990 Oct;6(10):1213.

PMID:
1702301
13.

Simian immunodeficiency virus from African green monkeys.

Daniel MD, Li Y, Naidu YM, Durda PJ, Schmidt DK, Troup CD, Silva DP, MacKey JJ, Kestler HW 3rd, Sehgal PK, et al.

J Virol. 1988 Nov;62(11):4123-8.

14.

Characterization of murine monoclonal antibodies to HIV-1 induced by synthetic peptides.

Durda PJ, Leece B, Jenoski A, Rabin H, Fisher A, Wong-Staal F.

AIDS Res Hum Retroviruses. 1988 Oct;4(5):331-42.

PMID:
2848556
15.

Tissue distribution, immunochemical characterization, and biosynthesis of 47D10, a tumor-associated surface glycoprotein.

Ho MK, Kato KP, Durda PJ, Murray JH, Wolfe H, Rabin H, Carney WP.

Cancer Res. 1987 Jan 1;47(1):241-50.

16.

Specific lysis of human tumor cells by T cells coated with anti-T3 cross-linked to anti-tumor antibody.

Perez P, Titus JA, Lotze MT, Cuttitta F, Longo DL, Groves ES, Rabin H, Durda PJ, Segal DM.

J Immunol. 1986 Oct 1;137(7):2069-72.

PMID:
2944946
17.

Lyt-1, Lyt-2, and Lyt-3 antigens.

Gottlieb PD, Reilly EB, Durda PJ, Niezgodka M.

Methods Enzymol. 1984;108:666-83. No abstract available.

PMID:
6084804
18.

Effects of iodipamide on human C3 and factor B in vitro.

Durda PJ, Pagano RJ, Bauman N, Brockman JA.

J Allergy Clin Immunol. 1982 Nov;70(5):353-60.

PMID:
6922882
19.

T100: a new murine cell surface glycoprotein detected by anti-Lyt-2.1 serum.

Durda PJ, Boos SC, Gottlieb PD.

J Immunol. 1979 Apr;122(4):1407-12.

PMID:
312840
21.

Partial molecular characterization of the Ly-1 alloantigen on mouse thymocytes.

Durda PJ, Shapiro C, Gottlieb PD.

J Immunol. 1978 Jan;120(1):53-7. No abstract available.

PMID:
304872
22.

The IB-peptide marker and the Ly-3 surface alloantigen: structural studies of a V kappa-region polymorphism and a T-cell marker determined by linked genes.

Gottlieb PD, Durda PJ.

Cold Spring Harb Symp Quant Biol. 1977;41 Pt 2:805-15. No abstract available.

PMID:
408079
23.
24.

A procedure for the separation of glucosamine from glucosaminitol.

Durda PJ, Cynkin MA.

Anal Biochem. 1974 Jun;59(2):407-9. No abstract available.

PMID:
4838775

Supplemental Content

Loading ...
Support Center